Allergenicity of partially hydrolyzed whey and casein formulas evaluated by ImmunoCAP inhibition assay and basophil

Takeshi Matsubara1, Fuka Ishikawa1, Chisato Inuo2

  • 1Health Care & Nutrition Science Institute, R&D Section, Morinaga Milk Industry Co., Ltd., Zama, Kanagawa, Japan.

Frontiers in Allergy
|August 7, 2023
PubMed

Insights

Partially hydrolyzed formulas (PHF) show varying tolerability in infants with cow's milk allergy (CMA). PHF1 and PHF2 demonstrate similar to higher tolerability compared to partially hydrolyzed whey formula (PHWF1), indicating formula composition impacts allergic responses.

Area of Science:

  • Allergy and Immunology
  • Pediatric Nutrition
  • Food Science

Background:

  • Partially hydrolyzed formula (PHF) is a common starter for infants when exclusive breastfeeding isn't feasible.
  • Infants with cow's milk allergy (CMA) may experience allergic reactions to cow's milk proteins.
  • Assessing the tolerability of different PHFs in infants with CMA is crucial for safe infant feeding.

Purpose of the Study:

  • To evaluate the in vitro and ex vivo characteristics of two whey and casein PHFs (PHF1, PHF2).
  • To compare the antigenicity and allergenic potential of PHF1 and PHF2 against a partially hydrolyzed whey formula (PHWF1).
  • To determine the tolerability of PHFs in infants diagnosed with CMA.

Main Methods:

  • Quantified residual antigenicity of β-lactoglobulin (β-LG) and casein using ELISA.
  • Determined molecular weight profiles via high-pressure liquid chromatography.
  • Assessed IgE reactivity (ImmunoCAP inhibition) and basophil activation (using blood from CMA patients) for each formula.

Main Results:

  • PHF1 exhibited similar β-LG and slightly higher casein antigenicity than PHWF1, with greater IgE reactivity but comparable basophil activation.
  • PHF2 demonstrated lower antigenicity, IgE reactivity, and basophil activation compared to PHWF1.
  • All participants (n=10) had casein-specific IgE, confirming CMA diagnosis.

Conclusions:

  • PHF1 and PHF2 show similar and improved tolerability, respectively, in infants with CMA compared to PHWF1.
  • The degree of IgE binding to PHFs does not always correlate with basophil activation, suggesting a complex immune response.
  • These findings aid in selecting appropriate starter formulas for infants with CMA.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
27.8K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
876
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
739
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.3K